Nemdx, Inc. today announced a poster presentation at the 2024 Northeast ALS Annual Conference (NEALS) hosted online on October 21-24. The poster, presented by Vito Levi D'Ancona, president of Nemdx, ...

New research from King's College London has revealed a connection between ancient viral DNA embedded in the human genome and ...

Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This ...

A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.

The DJC first reported in 2022 on architecture firm The Miller Hull Partnership's work in Spokane with Matt's Place ...

The study identified which specific HERVs are important in increasing susceptibility for neurodegenerative diseases.

TOKYO, Oct 16, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment ...

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

TOKYO, Oct 16, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” (mecobalamin) has received the ...

Hall, founder of Beacon of Hope for ALS, aims to lift people up and help them after their diagnosis. Amyotrophic lateral ...